2-parinarolyllecithin: fluorescent probe [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 6438869 |
| MeSH ID | M0095371 |
| Synonym |
|---|
| 2-parinarolyllecithin |
| [3-hydroxy-2-[(10z,12z,14z,16z)-octadeca-10,12,14,16-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate |
| 2-all-trans-parinoyllecithin |
| 77518-34-4 |
| 2-parinaroyl-pc |
| 2-prnl |
| 2-parinaroylphosphatidylcholine |
| parinaroyl-pc |
| 3,5,8-trioxa-4-phosphahexacosa-18,20,22,24-tetraen-1-aminium, 4-hydroxy-7-(hydroxymethyl)-n,n,n-trimethyl-9-oxo-, hydroxide, inner salt, 4-oxide, (all-e)- |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.09) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||